25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ACLX (Arcellx) Stock Analysis
Buy, Hold or Sell?

Let's analyze Arcellx together

I guess you are interested in Arcellx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Arcellx’s Financial Insights
  • 📈 Technical Analysis (TA) – Arcellx’s Price Targets

I'm going to help you getting a better view of Arcellx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Arcellx Inc

I send you an email if I find something interesting about Arcellx Inc.

1. Quick Overview

1.1. Quick analysis of Arcellx (30 sec.)










1.2. What can you expect buying and holding a share of Arcellx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
11.1%

What is your share worth?

Current worth
$7.54
Expected worth in 1 year
$6.08
How sure are you?
27.8%

+ What do you gain per year?

Total Gains per Share
$-1.47
Return On Investment
-2.2%

For what price can you sell your share?

Current Price per Share
$67.16
Expected price per share
$49.00 - $73.33
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Arcellx (5 min.)




Live pricePrice per Share (EOD)
$67.16
Intrinsic Value Per Share
$-27.90 - $-33.51
Total Value Per Share
$-20.36 - $-25.96

2.2. Growth of Arcellx (5 min.)




Is Arcellx growing?

Current yearPrevious yearGrowGrow %
How rich?$416.9m$385.4m$75m16.3%

How much money is Arcellx making?

Current yearPrevious yearGrowGrow %
Making money-$40.6m-$12.6m-$27.9m-68.9%
Net Profit Margin-318.3%-104.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Arcellx (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#146 / 881

Most Revenue
#227 / 881

Most Profit
#757 / 881

Most Efficient
#623 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Arcellx?

Welcome investor! Arcellx's management wants to use your money to grow the business. In return you get a share of Arcellx.

First you should know what it really means to hold a share of Arcellx. And how you can make/lose money.

Speculation

The Price per Share of Arcellx is $67.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arcellx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arcellx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $7.54. Based on the TTM, the Book Value Change Per Share is $-0.37 per quarter. Based on the YOY, the Book Value Change Per Share is $0.87 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arcellx.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.13-1.7%-0.74-1.1%-0.23-0.3%-0.61-0.9%-0.51-0.8%-0.51-0.8%
Usd Book Value Change Per Share-0.71-1.1%-0.37-0.5%0.871.3%0.290.4%0.420.6%0.420.6%
Usd Dividend Per Share0.000.0%0.000.0%0.370.5%0.120.2%0.080.1%0.080.1%
Usd Total Gains Per Share-0.71-1.1%-0.37-0.5%1.241.9%0.420.6%0.500.7%0.500.7%
Usd Price Per Share65.60-70.25-48.14-47.68-32.57-32.57-
Price to Earnings Ratio-14.55--27.36--31.35--22.65--15.43--15.43-
Price-to-Total Gains Ratio-92.65--418.90-26.85--134.00--123.52--123.52-
Price to Book Ratio8.69-8.44-6.85-6.88-4.78-4.78-
Price-to-Total Gains Ratio-92.65--418.90-26.85--134.00--123.52--123.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share67.16
Number of shares14
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.08
Usd Book Value Change Per Share-0.370.42
Usd Total Gains Per Share-0.370.50
Gains per Quarter (14 shares)-5.137.02
Gains per Year (14 shares)-20.5328.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-21-3152318
20-41-5294746
30-62-73147074
40-82-941894102
50-103-11523117130
60-123-13628141158
70-144-15732164186
80-164-17837188214
90-185-19942211242
100-205-22046235270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%5.011.02.027.8%5.011.02.027.8%5.011.02.027.8%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.016.011.1%2.00.016.011.1%2.00.016.011.1%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%5.011.02.027.8%5.011.02.027.8%5.011.02.027.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Arcellx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.708-0.367-48%0.875-181%0.294-341%0.419-269%0.419-269%
Book Value Per Share--7.5458.351-10%6.994+8%6.719+12%4.283+76%4.283+76%
Current Ratio--4.9285.000-1%4.482+10%5.227-6%5.719-14%5.719-14%
Debt To Asset Ratio--0.3570.356+0%0.468-24%0.384-7%0.815-56%0.815-56%
Debt To Equity Ratio--0.5550.552+0%0.925-40%0.676-18%0.723-23%0.723-23%
Dividend Per Share----0%0.368-100%0.124-100%0.082-100%0.082-100%
Enterprise Value--3936913038.4004174877537.850-6%2883078521.250+37%2871270177.033+37%2724382158.338+45%2724382158.338+45%
Eps---1.127-0.736-35%-0.229-80%-0.611-46%-0.515-54%-0.515-54%
Ev To Ebitda Ratio---14.285-30.899+116%-43.639+205%-28.558+100%-27.080+90%-27.080+90%
Ev To Sales Ratio--121.07668.235+77%26.982+349%45.284+167%45.284+167%45.284+167%
Free Cash Flow Per Share---1.157-0.555-52%-0.151-87%-0.065-94%-0.145-87%-0.145-87%
Free Cash Flow To Equity Per Share---1.147-0.648-43%0.669-271%0.492-333%0.530-316%0.530-316%
Gross Profit Margin--1.0001.011-1%1.020-2%1.010-1%1.007-1%1.007-1%
Intrinsic Value_10Y_max---33.505----------
Intrinsic Value_10Y_min---27.902----------
Intrinsic Value_1Y_max---0.710----------
Intrinsic Value_1Y_min---0.695----------
Intrinsic Value_3Y_max---4.150----------
Intrinsic Value_3Y_min---3.921----------
Intrinsic Value_5Y_max---10.023----------
Intrinsic Value_5Y_min---9.130----------
Market Cap3700965972.000+2%3624824038.4003873564037.850-6%2652698771.250+37%2628398010.367+38%1795187336.578+102%1795187336.578+102%
Net Profit Margin---7.660-3.183-58%-1.042-86%-1.534-80%-1.023-87%-1.023-87%
Operating Margin---8.669-3.401-61%-1.005-88%-1.590-82%-1.060-88%-1.060-88%
Operating Ratio--9.4764.632+105%2.328+307%2.548+272%1.699+458%1.699+458%
Pb Ratio8.901+2%8.6958.439+3%6.846+27%6.883+26%4.782+82%4.782+82%
Pe Ratio-14.899-2%-14.553-27.356+88%-31.353+115%-22.654+56%-15.434+6%-15.434+6%
Price Per Share67.160+2%65.60070.248-7%48.138+36%47.682+38%32.567+101%32.567+101%
Price To Free Cash Flow Ratio-14.513-2%-14.176-3.801-73%-13.142-7%-8.867-37%-6.236-56%-6.236-56%
Price To Total Gains Ratio-94.858-2%-92.654-418.898+352%26.855-445%-133.998+45%-123.517+33%-123.517+33%
Quick Ratio--8.9428.826+1%6.762+32%8.367+7%8.517+5%8.517+5%
Return On Assets---0.096-0.058-39%-0.022-77%-0.070-27%-0.105+9%-0.105+9%
Return On Equity---0.149-0.091-39%-0.051-66%-0.111-26%-0.112-25%-0.112-25%
Total Gains Per Share---0.708-0.367-48%1.243-157%0.417-270%0.502-241%0.502-241%
Usd Book Value--416906000.000460470000.000-9%385437000.000+8%370378250.000+13%236092222.222+77%236092222.222+77%
Usd Book Value Change Per Share---0.708-0.367-48%0.875-181%0.294-341%0.419-269%0.419-269%
Usd Book Value Per Share--7.5458.351-10%6.994+8%6.719+12%4.283+76%4.283+76%
Usd Dividend Per Share----0%0.368-100%0.124-100%0.082-100%0.082-100%
Usd Enterprise Value--3936913038.4004174877537.850-6%2883078521.250+37%2871270177.033+37%2724382158.338+45%2724382158.338+45%
Usd Eps---1.127-0.736-35%-0.229-80%-0.611-46%-0.515-54%-0.515-54%
Usd Free Cash Flow---63925000.000-30621750.000-52%-8314000.000-87%-3600666.667-94%-8009444.444-87%-8009444.444-87%
Usd Free Cash Flow Per Share---1.157-0.555-52%-0.151-87%-0.065-94%-0.145-87%-0.145-87%
Usd Free Cash Flow To Equity Per Share---1.147-0.648-43%0.669-271%0.492-333%0.530-316%0.530-316%
Usd Market Cap3700965972.000+2%3624824038.4003873564037.850-6%2652698771.250+37%2628398010.367+38%1795187336.578+102%1795187336.578+102%
Usd Price Per Share67.160+2%65.60070.248-7%48.138+36%47.682+38%32.567+101%32.567+101%
Usd Profit---62270000.000-40605000.000-35%-12636000.000-80%-33551416.667-46%-28281333.333-55%-28281333.333-55%
Usd Revenue--8129000.00019202250.000-58%32915750.000-75%18865333.333-57%12576888.889-35%12576888.889-35%
Usd Total Gains Per Share---0.708-0.367-48%1.243-157%0.417-270%0.502-241%0.502-241%
 EOD+5 -3MRQTTM+6 -32YOY+15 -253Y+15 -255Y+16 -2410Y+16 -24

3.3 Fundamental Score

Let's check the fundamental score of Arcellx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.899
Price to Book Ratio (EOD)Between0-18.901
Net Profit Margin (MRQ)Greater than0-7.660
Operating Margin (MRQ)Greater than0-8.669
Quick Ratio (MRQ)Greater than18.942
Current Ratio (MRQ)Greater than14.928
Debt to Asset Ratio (MRQ)Less than10.357
Debt to Equity Ratio (MRQ)Less than10.555
Return on Equity (MRQ)Greater than0.15-0.149
Return on Assets (MRQ)Greater than0.05-0.096
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Arcellx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.843
Ma 20Greater thanMa 5065.273
Ma 50Greater thanMa 10063.107
Ma 100Greater thanMa 20064.139
OpenGreater thanClose66.130
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Arcellx Inc

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; ARC-SparX programs in Phase 1 trials; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company preclinical product includes ACLX-003 for the treatment of AML and MDS. Further, the company focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize anitocabtagene autoleucel. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2025-06-17 16:11:08.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Arcellx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Net Profit Margin of -766.0% means that $-7.66 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arcellx Inc:

  • The MRQ is -766.0%. The company is making a huge loss. -2
  • The TTM is -318.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-766.0%TTM-318.3%-447.7%
TTM-318.3%YOY-104.2%-214.1%
TTM-318.3%5Y-102.3%-216.0%
5Y-102.3%10Y-102.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-766.0%-91.7%-674.3%
TTM-318.3%-139.0%-179.3%
YOY-104.2%-194.4%+90.2%
3Y-153.4%-248.5%+95.1%
5Y-102.3%-343.3%+241.0%
10Y-102.3%-488.9%+386.6%
4.3.1.2. Return on Assets

Shows how efficient Arcellx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • -9.6% Return on Assets means that Arcellx generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arcellx Inc:

  • The MRQ is -9.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-5.8%-3.8%
TTM-5.8%YOY-2.2%-3.6%
TTM-5.8%5Y-10.5%+4.7%
5Y-10.5%10Y-10.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-11.6%+2.0%
TTM-5.8%-11.7%+5.9%
YOY-2.2%-11.4%+9.2%
3Y-7.0%-11.9%+4.9%
5Y-10.5%-12.1%+1.6%
10Y-10.5%-13.8%+3.3%
4.3.1.3. Return on Equity

Shows how efficient Arcellx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • -14.9% Return on Equity means Arcellx generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arcellx Inc:

  • The MRQ is -14.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.9%TTM-9.1%-5.9%
TTM-9.1%YOY-5.1%-4.0%
TTM-9.1%5Y-11.2%+2.2%
5Y-11.2%10Y-11.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.9%-13.5%-1.4%
TTM-9.1%-15.0%+5.9%
YOY-5.1%-14.5%+9.4%
3Y-11.1%-16.9%+5.8%
5Y-11.2%-17.9%+6.7%
10Y-11.2%-19.9%+8.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Arcellx Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Arcellx is operating .

  • Measures how much profit Arcellx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • An Operating Margin of -866.9% means the company generated $-8.67  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arcellx Inc:

  • The MRQ is -866.9%. The company is operating very inefficient. -2
  • The TTM is -340.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-866.9%TTM-340.1%-526.8%
TTM-340.1%YOY-100.5%-239.6%
TTM-340.1%5Y-106.0%-234.1%
5Y-106.0%10Y-106.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-866.9%-229.2%-637.7%
TTM-340.1%-249.7%-90.4%
YOY-100.5%-208.4%+107.9%
3Y-159.0%-221.7%+62.7%
5Y-106.0%-344.1%+238.1%
10Y-106.0%-470.4%+364.4%
4.3.2.2. Operating Ratio

Measures how efficient Arcellx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 9.48 means that the operating costs are $9.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arcellx Inc:

  • The MRQ is 9.476. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.632. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.476TTM4.632+4.844
TTM4.632YOY2.328+2.304
TTM4.6325Y1.699+2.933
5Y1.69910Y1.6990.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.4762.108+7.368
TTM4.6322.680+1.952
YOY2.3283.080-0.752
3Y2.5483.621-1.073
5Y1.6994.734-3.035
10Y1.6996.546-4.847
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Arcellx Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Arcellx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.93 means the company has $4.93 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arcellx Inc:

  • The MRQ is 4.928. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.000. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.928TTM5.000-0.072
TTM5.000YOY4.482+0.518
TTM5.0005Y5.719-0.719
5Y5.71910Y5.7190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9283.659+1.269
TTM5.0003.834+1.166
YOY4.4824.141+0.341
3Y5.2274.661+0.566
5Y5.7195.756-0.037
10Y5.7196.151-0.432
4.4.3.2. Quick Ratio

Measures if Arcellx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Quick Ratio of 8.94 means the company can pay off $8.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arcellx Inc:

  • The MRQ is 8.942. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.826. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.942TTM8.826+0.116
TTM8.826YOY6.762+2.064
TTM8.8265Y8.517+0.310
5Y8.51710Y8.5170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9422.799+6.143
TTM8.8263.143+5.683
YOY6.7623.794+2.968
3Y8.3674.307+4.060
5Y8.5175.707+2.810
10Y8.5176.457+2.060
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Arcellx Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Arcellx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arcellx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Arcellx assets are financed with 35.7% credit (debt) and the remaining percentage (100% - 35.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arcellx Inc:

  • The MRQ is 0.357. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.356. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.357TTM0.356+0.001
TTM0.356YOY0.468-0.112
TTM0.3565Y0.815-0.460
5Y0.81510Y0.8150.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3570.324+0.033
TTM0.3560.347+0.009
YOY0.4680.329+0.139
3Y0.3840.340+0.044
5Y0.8150.349+0.466
10Y0.8150.379+0.436
4.5.4.2. Debt to Equity Ratio

Measures if Arcellx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arcellx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 55.5% means that company has $0.55 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arcellx Inc:

  • The MRQ is 0.555. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.552. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.555TTM0.552+0.002
TTM0.552YOY0.925-0.373
TTM0.5525Y0.723-0.170
5Y0.72310Y0.7230.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5550.379+0.176
TTM0.5520.435+0.117
YOY0.9250.412+0.513
3Y0.6760.446+0.230
5Y0.7230.460+0.263
10Y0.7230.509+0.214
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arcellx generates.

  • Above 15 is considered overpriced but always compare Arcellx to the Biotechnology industry mean.
  • A PE ratio of -14.55 means the investor is paying $-14.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arcellx Inc:

  • The EOD is -14.899. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.553. Based on the earnings, the company is expensive. -2
  • The TTM is -27.356. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.899MRQ-14.553-0.346
MRQ-14.553TTM-27.356+12.803
TTM-27.356YOY-31.353+3.998
TTM-27.3565Y-15.434-11.921
5Y-15.43410Y-15.4340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.899-2.282-12.617
MRQ-14.553-2.062-12.491
TTM-27.356-2.541-24.815
YOY-31.353-3.722-27.631
3Y-22.654-3.754-18.900
5Y-15.434-6.100-9.334
10Y-15.434-6.653-8.781
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arcellx Inc:

  • The EOD is -14.513. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.176. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.801. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.513MRQ-14.176-0.337
MRQ-14.176TTM-3.801-10.375
TTM-3.801YOY-13.142+9.341
TTM-3.8015Y-6.236+2.435
5Y-6.23610Y-6.2360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.513-3.101-11.412
MRQ-14.176-2.689-11.487
TTM-3.801-3.594-0.207
YOY-13.142-4.363-8.779
3Y-8.867-5.065-3.802
5Y-6.236-8.478+2.242
10Y-6.236-9.273+3.037
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Arcellx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.69 means the investor is paying $8.69 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arcellx Inc:

  • The EOD is 8.901. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.695. Based on the equity, the company is overpriced. -1
  • The TTM is 8.439. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.901MRQ8.695+0.207
MRQ8.695TTM8.439+0.255
TTM8.439YOY6.846+1.594
TTM8.4395Y4.782+3.657
5Y4.78210Y4.7820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.9011.932+6.969
MRQ8.6951.848+6.847
TTM8.4392.119+6.320
YOY6.8462.469+4.377
3Y6.8832.526+4.357
5Y4.7823.667+1.115
10Y4.7824.351+0.431
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Arcellx Inc.

4.8.1. Institutions holding Arcellx Inc

Institutions are holding 102.084% of the shares of Arcellx Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31FMR Inc11.44610.02646303679-1652954-20.7745
2025-03-31Paradigm Biocapital Advisors LP8.156613.496344920321204312.7548
2025-03-31Vanguard Group Inc7.23620.0047398515665506419.671
2025-03-31BlackRock Inc7.20420.005539675691135482.9462
2025-03-31NEA Management Company, LLC6.800618.9218374526200
2025-03-31RA Capital Management, LLC5.51373.326630365272492008.9405
2025-03-31Perceptive Advisors LLC5.31386.7642926478-552410-15.8789
2025-03-31Vestal Point Capital LP4.335611.185623877201912720402.6779
2025-03-31SR ONE CAPITAL MANAGEMENT, LP4.26139.5442234663000
2025-03-31T. Rowe Price Associates, Inc.3.34040.01491839624-281698-13.2794
2025-03-31State Street Corp3.02590.00451666451-108921-6.1351
2025-03-31T. Rowe Price Investment Management,Inc.3.02350.07231665138959216135.8813
2025-03-31HHG PLC2.74270.05631510494-46598-2.9926
2025-03-31Cormorant Asset Management, LLC1.90665.17921050000-250000-19.2308
2025-03-31AJU IB Investment Co Ltd1.902181.76571047557-333333-24.139
2025-03-31Geode Capital Management, LLC1.85310.00531020540415144.2403
2025-03-31Citadel Advisors Llc1.31850.0097261277009012778.4865
2025-03-31Capital World Investors1.28810.0075709374456496180.5203
2025-03-31JPMorgan Chase & Co1.24120.0033683581459125204.5501
2025-03-31Lord, Abbett & Co LLC1.20660.1553664526-310306-31.8317
Total 83.1165180.548445774465+2131995+4.7%

4.9.2. Funds holding Arcellx Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv3.20140.00671763110186611.0697
2025-05-31iShares Russell 2000 ETF1.99190.1106109697200
2025-03-31T. Rowe Price Health Sciences1.31250.3846722836-120954-14.3346
2025-03-31American Funds SMALLCAP World A1.28810.0678709374456496180.5203
2025-04-30Vanguard Small Cap Index1.2530.03269004131340.4562
2025-05-31SPDR® S&P Biotech ETF1.22250.890567327439760.5941
2025-03-31Fidelity Small Cap Growth1.16810.62764332500
2025-04-30Fidelity Growth Compy Commingled Pl S1.09060.049600619-500-0.0832
2025-04-30Fidelity Select Health Care1.08950.628460000000
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.0880.038259919858750.9902
2025-04-30Fidelity Select Biotechnology1.08710.9967598691-206600-25.6553
2025-03-31T. Rowe Price Small-Cap Stock0.96110.4482529305404938.284
2025-03-31T. Rowe Price US Small-Cap Core Equity0.96110.4482529305309091140.3594
2025-04-30Fidelity Growth Company Fund0.86860.0528478349-55800-10.4465
2025-03-31US Small-Cap Growth II Equity Comp0.83780.1879461380-65275-12.3943
2025-03-31T. Rowe Price New Horizons0.83780.1879461380-6240-1.3344
2025-03-31Fidelity Small Cap Index0.79350.118643701594792.2171
2025-04-30Vanguard Small Cap Growth Index Inv0.6970.07473838651680.0438
2025-05-31iShares Russell 2000 Growth ETF0.68910.213237949300
2025-04-30Fidelity Advisor Health Care I0.63550.637235000000
Total 23.07426.200212707532+392004+3.1%

5.3. Insider Transactions

Insiders are holding 14.504% of the shares of Arcellx Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-10Kavita PatelSELL150067.36
2025-05-20Kavita PatelSELL150058.43
2025-04-29Kavita PatelSELL150064.2
2025-04-08Kavita PatelSELL150057.5
2025-03-18Kavita PatelSELL150071.64
2025-02-26Rami ElghandourSELL3830062.02
2025-02-25Kavita PatelSELL150063.16
2025-02-24Christopher HeerySELL1015563.79
2025-02-04Kavita PatelSELL150064.57
2025-01-14Kavita PatelSELL150065.87
2025-01-08Christopher HeerySELL355373.69
2025-01-06Christopher HeerySELL306177.17
2025-01-03Christopher HeerySELL330179.55
2024-12-24Kavita PatelSELL150076.97
2024-12-03Kavita PatelSELL150091.88
2024-11-11Kavita PatelSELL15238105.92
2024-11-08Kavita PatelSELL33763104.14
2024-10-22Kavita PatelSELL150089.69
2024-09-17Michelle GilsonSELL1500077.73
2024-09-10Kavita PatelSELL150074.41
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets648,082
Total Liabilities231,176
Total Stockholder Equity416,906
 As reported
Total Liabilities 231,176
Total Stockholder Equity+ 416,906
Total Assets = 648,082

Assets

Total Assets648,082
Total Current Assets554,154
Long-term Assets93,928
Total Current Assets
Cash And Cash Equivalents 80,861
Short-term Investments 462,404
Other Current Assets 10,889
Total Current Assets  (as reported)554,154
Total Current Assets  (calculated)554,154
+/-0
Long-term Assets
Property Plant Equipment 69,171
Long Term Investments 21,942
Long-term Assets Other 2,815
Long-term Assets  (as reported)93,928
Long-term Assets  (calculated)93,928
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities112,461
Long-term Liabilities118,715
Total Stockholder Equity416,906
Total Current Liabilities
Short-term Debt 7,361
Accounts payable 4,369
Other Current Liabilities 43,359
Total Current Liabilities  (as reported)112,461
Total Current Liabilities  (calculated)55,089
+/- 57,372
Long-term Liabilities
Capital Lease Obligations 53,192
Long-term Liabilities Other 3,437
Long-term Liabilities  (as reported)118,715
Long-term Liabilities  (calculated)56,629
+/- 62,086
Total Stockholder Equity
Common Stock54
Retained Earnings -559,098
Accumulated Other Comprehensive Income 649
Other Stockholders Equity 975,301
Total Stockholder Equity (as reported)416,906
Total Stockholder Equity (calculated)416,906
+/-0
Other
Capital Stock54
Cash and Short Term Investments 543,265
Common Stock Shares Outstanding 55,256
Current Deferred Revenue57,372
Liabilities and Stockholders Equity 648,082
Net Debt -27,669
Net Invested Capital 416,906
Net Working Capital 441,693
Property Plant and Equipment Gross 69,171
Short Long Term Debt Total 53,192



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
57,694
0
0
144,963
128,782
243,390
375,326
337,327
313,817
622,943
623,528
614,218
825,132
779,695
734,306
764,909
711,327
648,082
648,082711,327764,909734,306779,695825,132614,218623,528622,943313,817337,327375,326243,390128,782144,9630057,694
   > Total Current Assets 
49,357
46,596
0
134,139
112,809
220,903
325,747
290,305
266,863
571,367
558,070
491,456
716,363
588,733
530,203
587,301
599,310
554,154
554,154599,310587,301530,203588,733716,363491,456558,070571,367266,863290,305325,747220,903112,809134,139046,59649,357
       Cash And Cash Equivalents 
46,596
-46,596
0
70,027
104,617
127,160
164,540
56,763
64,179
274,892
303,665
126,119
394,583
154,782
100,233
161,846
105,679
80,861
80,861105,679161,846100,233154,782394,583126,119303,665274,89264,17956,763164,540127,160104,61770,0270-46,59646,596
       Short-term Investments 
0
93,192
0
61,155
73,784
83,769
142,446
224,018
190,656
258,701
202,819
313,597
307,434
419,345
416,663
412,408
481,696
462,404
462,404481,696412,408416,663419,345307,434313,597202,819258,701190,656224,018142,44683,76973,78461,155093,1920
       Net Receivables 
0
0
0
0
0
0
0
0
0
21,230
29,431
33,155
0
3,100
3,200
3,400
0
0
003,4003,2003,100033,15529,43121,230000000000
       Other Current Assets 
2,761
0
0
2,957
8,192
9,974
3,191
16,433
12,028
16,544
22,155
13,137
14,346
11,506
13,515
13,047
11,935
10,889
10,88911,93513,04713,51511,50614,34613,13722,15516,54412,02816,4333,1919,9748,1922,957002,761
   > Long-term Assets 
8,337
-46,596
0
10,824
15,973
22,487
49,579
47,022
46,954
44,066
51,671
109,884
96,995
190,962
204,103
177,608
112,017
93,928
93,928112,017177,608204,103190,96296,995109,88451,67144,06646,95447,02249,57922,48715,97310,8240-46,5968,337
       Property Plant Equipment 
4,900
0
0
6,781
10,318
13,375
37,109
39,003
39,890
44,066
51,671
66,924
69,827
69,126
70,341
71,431
70,245
69,171
69,17170,24571,43170,34169,12669,82766,92451,67144,06639,89039,00337,10913,37510,3186,781004,900
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
42,960
27,168
117,102
130,128
102,428
38,277
21,942
21,94238,277102,428130,128117,10227,16842,96000000000000
       Other Assets 
3,437
0
0
0
5,655
9,112
12,470
8,019
7,064
7,510
13,787
12,878
11,774
0
0
0
0
0
0000011,77412,87813,7877,5107,0648,01912,4709,1125,6550003,437
> Total Liabilities 
121,414
0
0
248,758
250,297
21,799
59,370
101,043
108,863
319,226
329,861
348,090
339,752
283,122
247,142
281,891
256,535
231,176
231,176256,535281,891247,142283,122339,752348,090329,861319,226108,863101,04359,37021,799250,297248,75800121,414
   > Total Current Liabilities 
5,271
0
0
13,261
14,845
16,808
32,053
44,777
56,693
166,057
156,114
173,149
118,238
107,901
88,290
137,017
125,405
112,461
112,461125,405137,01788,290107,901118,238173,149156,114166,05756,69344,77732,05316,80814,84513,261005,271
       Short-term Debt 
0
0
0
0
0
370
2,313
61,206
35,961
80,482
88,312
109,736
46,784
39,677
52,838
18,118
7,538
7,361
7,3617,53818,11852,83839,67746,784109,73688,31280,48235,96161,2062,31337000000
       Accounts payable 
504
0
0
1,583
1,333
1,874
7,556
2,962
9,053
4,532
5,693
7,185
2,619
3,099
4,868
5,989
2,095
4,369
4,3692,0955,9894,8683,0992,6197,1855,6934,5329,0532,9627,5561,8741,3331,58300504
       Other Current Liabilities 
4,767
0
0
11,678
13,512
14,564
22,184
-19,391
11,679
-26,244
-31,766
-37,952
18,302
33,933
15,614
112,910
56,716
43,359
43,35956,716112,91015,61433,93318,302-37,952-31,766-26,24411,679-19,39122,18414,56413,51211,678004,767
   > Long-term Liabilities 
116,143
0
0
235,497
235,452
4,991
27,317
56,266
52,170
153,169
173,747
174,941
221,514
175,221
158,852
144,874
131,130
118,715
118,715131,130144,874158,852175,221221,514174,941173,747153,16952,17056,26627,3174,991235,452235,49700116,143
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
4,844
27,200
25,663
52,170
7,166
5,323
-1,017
50,841
47,685
21,453
47,214
46,542
45,831
45,83146,54247,21421,45347,68550,841-1,0175,3237,16652,17025,66327,2004,84400000
       Other Liabilities 
1,882
0
0
0
1,896
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,8960001,882
       Long-term Liabilities Other 
19
0
0
206
178
4,991
27,317
4,624
0
153,169
173,747
0
0
15,468
14,899
15,048
8,593
3,437
3,4378,59315,04814,89915,46800173,747153,16904,62427,3174,9911782060019
       Deferred Long Term Liability 
1,761
0
0
0
3,172
8,913
9,969
5,518
0
0
0
0
0
0
0
0
0
0
00000000005,5189,9698,9133,1720001,761
> Total Stockholder Equity
-63,720
50,541
0
-103,795
-121,515
221,591
315,956
236,284
204,954
303,717
293,667
266,128
485,380
496,573
487,164
483,018
454,792
416,906
416,906454,792483,018487,164496,573485,380266,128293,667303,717204,954236,284315,956221,591-121,515-103,795050,541-63,720
   Common Stock
1
0
0
1
1
36
44
44
44
48
48
48
52
53
53
53
53
54
5453535353524848484444443611001
   Retained Earnings -559,098-496,828-449,747-423,880-396,678-389,480-409,324-369,988-346,134-318,790-279,798-194,587-162,496-130,111-109,44100-65,142
   Accumulated Other Comprehensive Income 
-114,261
-63,720
0
-5
-20
-44
-262
-399
-221
86
-7
-65
547
-512
-792
1,899
848
649
6498481,899-792-512547-65-786-221-399-262-44-20-50-63,720-114,261
   Capital Surplus 
0
0
0
0
0
384,095
510,761
384,095
0
649,717
663,614
0
0
0
0
0
0
0
0000000663,614649,7170384,095510,761384,09500000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
115,682
0
0
-227,729
-216,149
384,095
510,761
516,437
523,921
649,717
663,614
675,469
874,261
893,710
911,783
930,813
950,719
975,301
975,301950,719930,813911,783893,710874,261675,469663,614649,717523,921516,437510,761384,095-216,149-227,72900115,682



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue107,936
Cost of Revenue-5,188
Gross Profit102,748102,748
 
Operating Income (+$)
Gross Profit102,748
Operating Expense-245,507
Operating Income-137,571-142,759
 
Operating Expense (+$)
Research Development157,093
Selling General Administrative88,414
Selling And Marketing Expenses0
Operating Expense245,507245,507
 
Net Interest Income (+$)
Interest Income33,322
Interest Expense-1,030
Other Finance Cost-0
Net Interest Income32,292
 
Pretax Income (+$)
Operating Income-137,571
Net Interest Income32,292
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-105,279-169,863
EBIT - interestExpense = -105,279
-105,279
-106,318
Interest Expense1,030
Earnings Before Interest and Taxes (EBIT)-104,249-104,249
Earnings Before Interest and Taxes (EBITDA)-99,061
 
After tax Income (+$)
Income Before Tax-105,279
Tax Provision-2,069
Net Income From Continuing Ops-107,348-107,348
Net Income-107,348
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses245,507
Total Other Income/Expenses Net32,292-32,292
 

Technical Analysis of Arcellx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arcellx. The general trend of Arcellx is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arcellx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Arcellx Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arcellx Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 69.08 < 69.84 < 73.33.

The bearish price targets are: 60.92 > 49.42 > 49.00.

Know someone who trades $ACLX? Share this with them.👇

Arcellx Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arcellx Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arcellx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arcellx Inc. The current macd is 0.70087349.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arcellx price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Arcellx. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Arcellx price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Arcellx Inc Daily Moving Average Convergence/Divergence (MACD) ChartArcellx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arcellx Inc. The current adx is 15.24.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Arcellx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Arcellx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arcellx Inc. The current sar is 63.13.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Arcellx Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arcellx Inc. The current rsi is 59.84. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Arcellx Inc Daily Relative Strength Index (RSI) ChartArcellx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arcellx Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arcellx price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Arcellx Inc Daily Stochastic Oscillator ChartArcellx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arcellx Inc. The current cci is 91.25.

Arcellx Inc Daily Commodity Channel Index (CCI) ChartArcellx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arcellx Inc. The current cmo is 29.12.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Arcellx Inc Daily Chande Momentum Oscillator (CMO) ChartArcellx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arcellx Inc. The current willr is -9.69609262.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Arcellx Inc Daily Williams %R ChartArcellx Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arcellx Inc.

Arcellx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arcellx Inc. The current atr is 2.85150507.

Arcellx Inc Daily Average True Range (ATR) ChartArcellx Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arcellx Inc. The current obv is 10,630,279.

Arcellx Inc Daily On-Balance Volume (OBV) ChartArcellx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arcellx Inc. The current mfi is 52.81.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Arcellx Inc Daily Money Flow Index (MFI) ChartArcellx Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arcellx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Arcellx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arcellx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.843
Ma 20Greater thanMa 5065.273
Ma 50Greater thanMa 10063.107
Ma 100Greater thanMa 20064.139
OpenGreater thanClose66.130
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Arcellx with someone you think should read this too:
  • Are you bullish or bearish on Arcellx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arcellx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arcellx Inc

I send you an email if I find something interesting about Arcellx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arcellx Inc.

Receive notifications about Arcellx Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.